Beyond Air Secures Third Major GPO Deal, Expanding LungFit PH Access to 2,000 Hospitals
Event summary
- Beyond Air signed a national group purchasing agreement with a top 3 U.S. GPO, effective April 1, 2026.
- The deal expands LungFit PH access to nearly 2,000 additional U.S. hospitals and health systems.
- This is Beyond Air's third major GPO partnership, following agreements with Vizient and Premier, Inc.
- LungFit PH uses Plasma Pulse Technology to generate nitric oxide on demand, reducing supply chain dependencies.
The big picture
This GPO expansion positions Beyond Air to challenge established nitric oxide delivery systems by leveraging hospital procurement networks. The deal underscores a broader industry shift toward tankless, on-demand therapeutic gas solutions that reduce logistical complexity. With three major GPO partnerships now in place, Beyond Air appears to be executing a deliberate strategy to dominate the U.S. hospital market for inhaled nitric oxide therapies.
What we're watching
- Adoption Pace
- How quickly hospitals will transition from traditional nitric oxide systems to LungFit PH.
- Market Penetration
- Whether Beyond Air can sustain this GPO-driven growth strategy in other markets.
- Competitive Response
- How existing nitric oxide providers will react to Beyond Air's expanding hospital footprint.
Related topics